SAHPRA to evaluate Sputnik V COVID-19 vaccine data for possible use in SA

The Health Department said that the company developing the inoculation had submitted documentation for registration in the country.

A nurse shows the Sputnik V (Gam-COVID-Vac) vaccine against the coronavirus disease (COVID-19) at a clinic in Moscow on December 5, 2020, amid the ongoing coronavirus disease pandemic. Picture: AFP

CAPE TOWN - Russia's Sputnik V coronavirus vaccine will be evaluated locally to possibly be added to South Africa's COVID-19 arsenal.

The South African Health Products Regulatory Authority (SAHPRA) said that it would proceed with evaluating data on the vaccine's efficacy, safety and quality.

The Health Department said that the company developing the inoculation had submitted documentation for registration in the country.

READ: Govt evaluating Sputnik V vaccine, mulls China's Sinopharm offer - Mkhize

It comes as the country awaits the second shipment of the Johnson & Johnson vaccine, which is expected to arrive in South Africa on Saturday.

The Russian vaccine, named after the Soviet-era satellite, was registered in August before clinical trials were under way, which left experts wary.

But leading medical journal The Lancet published results showing the jab to be safe and 91.6% effective.

According to the Russian Direct Investment Fund, which financed the vaccine's development, more than 30 countries have so far approved the Sputnik V vaccine.

Additional reporting by AFP.

Download the Eyewitness News app to your iOS or Android device.